Palomar Medical Technologies (Nasdaq: PMTI) reported earnings on Feb. 7. Here are the numbers you need to know.

The 10-second takeaway
 For the quarter ended Dec. 31 (Q4), Palomar Medical Technologies beat expectations on revenues and beat expectations on earnings per share.

Compared to the prior-year quarter, revenue grew slightly and GAAP earnings per share increased.

Margins expanded across the board.

Revenue details
 Palomar Medical Technologies reported revenue of $23.4 million. The four analysts polled by S&P Capital IQ predicted sales of $22.8 million on the same basis. GAAP reported sales were the same as the prior-year quarter's.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
 EPS came in at $0.12. The one earnings estimate compiled by S&P Capital IQ anticipated $0.04 per share. GAAP EPS were $0.12 for Q4 compared to -$0.10 per share for the prior-year quarter.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
 For the quarter, gross margin was 57.3%, 10,220 basis points better than the prior-year quarter. Operating margin was 9.6%, 11,380 basis points better than the prior-year quarter. Net margin was 9.7%, 1,810 basis points better than the prior-year quarter.

Looking ahead
 Next quarter's average estimate for revenue is $20.4 million. On the bottom line, the average EPS estimate is -$0.02.

Next year's average estimate for revenue is $88.9 million. The average EPS estimate is $0.10.

Investor sentiment
 The stock has a three-star rating (out of five) at Motley Fool CAPS, with 495 members out of 525 rating the stock outperform, and 30 members rating it underperform. Among 146 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 139 give Palomar Medical Technologies a green thumbs-up, and seven give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Palomar Medical Technologies is outperform, with an average price target of $11.88.

Is Palomar Medical Technologies the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.